The stock's fall snapped a four-day winning streak.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, and a low estimate of $22.00. This current average has decreased by 0.72% from the previous average price target of $23.75.

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is taking big steps in its strategic review that has now resulted in a leadersh | Along with the CEO transition announcement,

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company to unlock shareholder value and

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Skillman, New Jersey-based Kenvue Inc. (KVUE) operates as a global consumer health company. Valued at $41.9 billion by market cap, the company offers a consumer health portfolio in self-care, skin health & beauty,

We recently published 10 Stocks Jim Cramer Discussed As He Commented On Latest Tariffs. Kenvue Inc. (NYSE:KVUE) is one of the stocks Jim Cramer recently discussed. Kenvue Inc. (NYSE:KVUE) is a consumer goods company whose shares are flat year-to-date.